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AbstrAct
Objective
To investigate whether risk of infection with severe 
acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) and outcomes of coronavirus disease 2019 
(covid-19) differed between adults living with and 
without children during the first two waves of the UK 
pandemic.
Design
Population based cohort study, on behalf of NHS 
England.
setting
Primary care data and pseudonymously linked 
hospital and intensive care admissions and death 
records from England, during wave 1 (1 February to 
31 August 2020) and wave 2 (1 September to 18 
December 2020).
ParticiPants
Two cohorts of adults (18 years and over) registered 
at a general practice on 1 February 2020 and 1 
September 2020.
Main OutcOMe Measures
Adjusted hazard ratios for SARS-CoV-2 infection, 
covid-19 related admission to hospital or intensive 
care, or death from covid-19, by presence of children 
in the household.
results
Among 9 334 392adults aged 65 years and under, 
during wave 1, living with children was not associated 
with materially increased risks of recorded SARS-
CoV-2 infection, covid-19 related hospital or intensive 
care admission, or death from covid-19. In wave 2, 
among adults aged 65 years and under, living with 
children of any age was associated with an increased 
risk of recorded SARS-CoV-2 infection (hazard ratio 
1.06 (95% confidence interval 1.05 to 1.08) for living 
with children aged 0-11 years; 1.22 (1.20 to 1.24) for 
living with children aged 12-18 years) and covid-19 
related hospital admission (1.18 (1.06 to 1.31) for 
living with children aged 0-11; 1.26 (1.12 to 1.40) for 
living with children aged 12-18). Living with children 
aged 0-11 was associated with reduced risk of death 
from both covid-19 and non-covid-19 causes in 
both waves; living with children of any age was also 
associated with lower risk of dying from non-covid-19 
causes. For adults 65 years and under during wave 2, 
living with children aged 0-11 years was associated 
with an increased absolute risk of having SARS-CoV-2 
infection recorded of 40-60 per 10 000 people, from 
810 to between 850 and 870, and an increase in the 
number of hospital admissions of 1-5 per 10 000 
people, from 160 to between 161 and 165. Living 
with children aged 12-18 years was associated with 
an increase of 160-190 per 10 000 in the number 
of SARS-CoV-2 infections and an increase of 2-6 per 
10 000 in the number of hospital admissions.
cOnclusiOns
In contrast to wave 1, evidence existed of increased 
risk of reported SARS-CoV-2 infection and covid-19 
outcomes among adults living with children during 
wave 2. However, this did not translate into a 
materially increased risk of covid-19 mortality, and 
absolute increases in risk were small.
Introduction
The role of children and adolescents in the transmission 
of severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2) is uncertain.1 2 Good evidence indicates 
that they have lower susceptibility to infection and 
are less likely to have severe disease once infected.1 3 4 
Modelling of other respiratory tract infections such as 
influenza suggests that children are a major driver of 
1Electronic Health Records 
Research Group, Faculty of 
Epidemiology and Population 
Health, London School of 
Hygiene and Tropical Medicine, 
London, UK
2The DataLab, Nuffield 
Department of Primary Care 
Health Sciences, University of 
Oxford, Oxford OX2 6GG, UK
3The Phoenix Partnership, 129 
Low Lane, Horsforth, Leeds, UK
4Centre for Mathematical 
Modelling of Infectious Diseases, 
London School of Hygiene & 
Tropical Medicine, London, UK
Correspondence to: B Goldacre 
ben.goldacre@phc.ox.ac.uk  
(or @bengoldacre on Twitter: 
ORCID 0000-0002-5127-4728)
Additional material is published 
online only. To view please visit 
the journal online.
cite this as: BMJ 2021;372:n628 
http://dx.doi.org/10.1136/bmj.n628
Accepted: 7 March 2021
WhAt Is AlreAdy knoWn on thIs topIc
Adults living with children have more “common colds” than do those not living 
with children
This could result in a lower risk of serious outcomes from SARS-CoV-2 infection 
due to cross protective immunity from other seasonal coronaviruses
Alternatively, living with children may lead to greater opportunities for infection 
with SARS-CoV-2 and increased risks to adults they live with
WhAt thIs study Adds
During the first wave of the pandemic in the UK, living with children of any age 
was not associated with an increased risk of severe outcomes from covid-19, 
compared with not living with children
Risk of SARS-CoV-2 infection and covid-19 related hospital admission was 
increased for adults aged 65 years and under living with children of any age 
during the second wave, compared with those not living with children
Absolute increases in risks of SARS-CoV-2 infection and covid-19 related hospital 
admission among adults living with children in wave 2 were small
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transmission during the initial phase of an epidemic, 
in part owing to a high frequency of social contacts.5 
By contrast, accruing evidence suggests that for 
SARS-CoV-2 lower susceptibility and possibly lower 
infectiousness, particularly among younger children, 
means that they may not transmit infection more than 
adults.6
Proposed explanatory mechanisms for lower 
susceptibility or propensity to disease among chil-
dren include age dependent expression of the 
angiotensin converting enzyme 2 gene, differences 
in innate and adaptive immunity, more frequent 
respiratory infections, and pre-existing immunity to 
coronaviruses.7-9 Four seasonal coronaviruses usually 
cause self-limiting “common cold”-like syndromes, 
although coronaviruses are only one group of viruses 
responsible, causing 10-30% of common colds in 
adults.10 Children have more colds each year than do 
adults, with the highest infection frequency in young 
children.11-13 Adults in close contact with children also 
have a higher frequency of viral respiratory infections, 
especially women and adults exposed to younger 
children.14
If recent coronavirus infection is protective against 
SARS-CoV-2 infection, then adults living with children 
may be at a lower risk than those living without 
children. Conversely, children, or activities associated 
with childcare, could mean that adults living with 
children may have an increased risk of exposure to 
SARS-CoV-2 infection. Once infection has occurred, 
potential cross reactive immunity, and better health 
among adults living with children, could also affect 
the severity of illness with coronavirus disease 2019 
(covid-19). Therefore, quantifying the overall effect 
of living with children on the risk of SARS-CoV-2 
infections and severe outcomes from covid-19 is 
important. We conducted a large cohort study using 
UK electronic health records with linked data on 
household members to determine whether the risk 
of infection and covid-19 outcomes differs between 
adults living with and without school age children.
Methods
Database description
Primary care records managed by the general practice 
software provider The Phoenix Partnership (TPP) 
were linked to Secondary Uses Service hospital 
admissions, SARS-CoV-2 testing data from the Second 
Generation Surveillance System, Intensive Care 
National Audit and Research Centre (ICNARC) covid-
19-related intensive care unit (ICU) admissions,15 
and Office for National Statistics mortality records 
through OpenSAFELY, a data analytics platform 
created on behalf of NHS England to help to answer 
urgent research questions related to covid-19 (https://
opensafely.org).
OpenSAFELY provides a secure software interface 
allowing the analysis of pseudonymised primary care 
patient records from England in near real time within 
the electronic health records vendor’s highly secure 
data centre, avoiding the need for large volumes of 
potentially disclosive pseudonymised patient data to be 
transferred off site. This, in addition to other technical 
and organisational controls, minimises any risk of 
re-identification. Similarly, pseudonymised datasets 
from other data providers are securely provided to 
the electronic health records vendor and linked to 
the primary care data. The dataset analysed within 
OpenSAFELY is based on 24 million people currently 
registered with general practice surgeries and uses TPP 
SystmOne software. It includes pseudonymised data 
such as coded diagnoses, drugs, and physiological 
parameters. No free text data are included. An index 
of multiple deprivation is available, which ranks every 
lower layer super output area on the basis of various 
characteristics of the region.16
study design and population
Our pre-specified study protocol and post hoc protocol 
amendments (supplementary table A1) are available.17 
We extracted two separate study populations for 
each wave of the pandemic. These study populations 
included all adults aged 18 years or over, registered 
in an English general practice with TPP software. The 
first cohort included people registered on 1 February 
2020 (study start for first wave), and the second cohort 
included those registered on 1 September 2020 (study 
start for second wave). We followed participants until 
the earliest of development of the outcome of interest, 
deregistration from their general practice, death from 
any cause, or study end. Study end was 31 August for 
the first wave cohort and 18 December for the second 
wave cohort, except for covid-19 related hospital 
admissions, for which study end was 30 November 
2020.
Inclusion and exclusion criteria
We required participants to have at least three 
months of follow-up before study start (1 February or 
1 September). This sought to ensure that a patient’s 
health record had been updated following any recent 
change of general practice, while minimising loss of 
households moving home more frequently, potentially 
related to having children.
The pseudonymised household identifier developed 
by TPP links people living at the same address on 
1 February 2020 (see supplementary methods). We 
excluded people with no household identifier and 
those living in care homes (derived by TPP from 
linking addresses matched to publicly available Care 
Quality Commission data) or household sizes above 10 
people (possible care homes or other institutions). We 
excluded households in which any individual had a 
missing record of age, to avoid misclassifying our main 
exposure variable (household exposure to children). 
Finally, we excluded people with missing ethnicity, 
sex, or index of multiple deprivation.
study measures
Exposures
The primary exposure was an ordered categorical 
variable reflecting school stages, derived using the 
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ages of individuals linked by the household identifier: 
no children under 18 years in the household, only 
children aged 0-11 years in the household, only 
children aged 12-18 years in the household, and at 
least one child aged 0-11 years and at least one aged 
12-18 years in the household.
Outcomes
We included four outcomes: evidence of SARS-CoV-2 
infection, defined as the earliest of either a covid-19 code 
recorded in primary care (specifically, a code indicating 
a clinical diagnosis of covid-19, a positive swab test 
for SARS-CoV-2, or having sequelae of covid-19 (see 
supplementary methods)) or having a positive covid-19 
test in Second Generation Surveillance System data; 
hospital admission for covid-19 defined as an ICD-10 
(international classification of diseases, 10th revision) 
code for covid-19 in the primary diagnosis field 
(ascertained from Secondary Uses Service data); ICU 
admission with covid-19 that required non-invasive or 
invasive respiratory support (ascertained from ICNARC 
data); and covid-19 related death, defined as an ICD-
10 code for covid-19 anywhere on the death certificate 
(ascertained from Office for National Statistics death 
certificate data). Participants were able to develop 
each outcome. Retrospectively, to contextualise our 
findings, we added the outcome of non-covid-19 
death, defined as death from any other cause on the 
death certificate.
In the UK, testing for SARS-CoV-2 outside of hos-
pitals has been predominantly done among people 
who have developed symptoms suggestive of infection 
and requested a test.18 Availability of tests for SARS-
CoV-2 have changed markedly over the period of the 
study. During wave 1, capacity outside hospitals 
was limited, so swab tests were predominantly 
available to people in high risk jobs or on admission 
to hospital. During wave 2, tests were much more 
readily available. In both waves, admission to 
hospital in the UK has been based on severity of 
illness and clinical need, with general guidance 
available about admission criteria for patients and 
clinicians.19
Covariates
We used a directed-acyclic graph approach to determine 
covariates (supplementary figure A1), considering 
demographics including age in years, sex, body mass 
index (kg/m2), smoking status, index of multiple 
deprivation, ethnicity, geographic area, and the total 
number of adults in the household. We identified 
chronic comorbidities that are associated with the risk 
of severe covid-19 outcomes.20 These are defined with 
links to code lists in the supplementary methods, with 
further information about demographic covariates. 
We identified participants who were recommended to 
shield following the UK government’s identification of 
clinically extremely vulnerable groups.21 In the main 
analysis, we assumed people with missing body mass 
index to be non-obese and those with missing smoking 
information to be non-smokers.
statistical analysis
Primary model
We analysed outcomes separately for adults aged 18-
65 years, those most likely to be parents or primary 
caregivers and also of working age, and older adults 
(over 65 years). We described the proportion of 
individuals within each exposure and outcome, by 
the covariates. We then described the rate of outcomes 
according to the presence of children in the household.
We used Cox proportional hazards modelling to 
determine hazard ratios for each outcome, using robust 
standard errors to account for clustering by household 
identifier and stratifying by geographic area (through 
the Sustainability and Transformation Partnership, an 
NHS administrative region) to allow for geographical 
variation in infection rates. We analysed the association 
between exposure and outcome separately for each 
wave rather than comparing results between waves.
We wished to adjust for illness in early adult life, 
which could have affected the ability or decision to have 
children, as a confounder but were concerned about 
the accuracy of dates of onset of illness in the primary 
care record. Therefore, we used comorbidities at study 
start as a proxy for earlier health problems, as well as a 
marker of differences in current health status between 
adults living with and without children. To show the 
effect of this adjustment, we present a “demographic 
adjusted model,” adjusted for sex, age using a four knot 
cubic spline, index of multiple deprivation, body mass 
index, smoking, ethnicity, and total number of adults 
in the household, and then a “comorbidity adjusted 
model” with the addition of clinical comorbidities at 
study start. We explored violations of the proportional 
hazards assumption by testing for a zero slope in the 
scaled Schoenfeld residuals.
Secondary models
We examined possible interactions between our 
primary exposure and sex of the adult and probable 
shielding behaviour of the adult. In relation to 
the possibility cross reactive immunity from other 
coronavirus infections, we also examined for evidence 
of a “dose-response effect” of exposure to previous 
coronavirus infections by re-categorising the number 
of children, in households with only children aged 
0-11 years, as one, two, three, and four or more.
Sensitivity analyses
To confirm that our household identifier correctly 
linked adults in close contact with children we did a 
similar analysis over an earlier time period (1 February 
2019 to 1 February 2020), in which the outcome was 
a Read code for threadworm infection, a condition 
for which we would anticipate transmission from 
children to adults, with the strongest association seen 
in younger children.
Secondly, we repeated the comorbidity adjusted 
model: restricting to participants with complete 
body mass index and smoking data; using age as the 
underlying timescale, to ensure that we had fully 
adjusted for age as a confounder; requiring 12 months 
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or more primary care follow-up before study start, to 
fully capture pre-existing comorbidities; fitting time 
interactions on covariates where evidence existed 
of non-proportional hazards; censoring the study 
period on 1 November for the outcome covid-19 
related hospital admission, owing to potential delays 
in availability of Secondary Uses Service data; and 
splitting the “only children 0-11 years” group into 
children aged 0-4 (pre-school) and 5-11 years (primary 
school).
As data on occupation (related to risk of SARS-
CoV-2 infection22) were not available, we used 
quantitative bias analysis to assess the potential extent 
of confounding from high risk occupation among 
adults 65 years and under. We calculated bias adjusted 
hazard ratios under a range of plausible assumptions 
about the association between occupation and risk 
of infection and prevalence of high risk occupations 
among people with and without children.23-26
We carried out an additional post hoc sensitivity 
analysis using multiple imputation to include 
individuals initially excluded owing to missing 
ethnicity data. We used a population calibrated 
imputation approach, with marginal proportions 
of each ethnicity group within each of nine broad 
geographical regions of England (East, East Midlands, 
London, North East, North West, South East, South 
West, West Midlands, Yorkshire and The Humber) 
taken from Annual Population Survey data (pooled 
2014-16). Five imputed datasets were created with 
estimated hazard ratios combined using Rubin’s 
rules.27
Finally, to quantify the absolute risk associated with 
living with children in wave 2, we estimated a range 
of increases in SARS-CoV-2 infections and hospital 
admissions with covid-19 for each exposure category 
by multiplying the bounds of the 95% confidence 
intervals by the rate of each outcome in people not 
living with children and expressed this per 10 000 
people.
Software and reproducibility
We used Python 3.8 and SQL (Server 2016 Enterprise 
SP2) for data management and Stata 16 for analysis. 
The analysis code is available online.28
Patient and public involvement
Neither patients nor the public were involved in 
developing the research question and study or in the 
design, management, or interpretation of this study. 
The primary barrier was the rapid timescale of analysis 
to deliver timely results.
results
The final cohort for wave 1 included 9 334 392 adults 
65 years or under and 2 684 524 adults over 65 
years (supplementary figure A2): wave 2 had similar 
numbers. In both waves, among people 65 years and 
under, 63% did not live with children, 20% lived 
with only children aged 0-11 years, 10% lived with 
only children aged 12-18 years, and 7% lived with 
children aged 0-11 and 12-18 years (table 1). Those 
living with children were more likely to be younger, 
female, and of non-white ethnicity, to have a lower 
index of multiple deprivation, to have more adults 
in the household, and to have fewer comorbidities 
(supplementary table A3). In wave 1, a total of 51 560 
(0.55%) had recorded SARS-CoV-2 infection, 6374 
(0.07%) were admitted to hospital with covid-19, 
1601 (0.02%) were admitted to ICU for ventilatory 
support with covid-19, and 1219 (0.01%) died of 
covid-19 (supplementary table A3). In wave 2, a 
total of 241 693 (2.61%) had recorded SARS-CoV-2 
infection, 3616 (0.04%) were admitted to hospital 
with covid-19, 1102 (0.01%) were admitted to ICU for 
ventilatory support with covid-19, and 591 (0.01%) 
died of covid-19 (supplementary table A3). The vast 
majority of diagnoses for the outcome SARS-CoV-2 
infection, particularly in wave 2, came from swab 
testing (supplementary table A4).
Among people over 65 years, 97% did not live 
with children (supplementary table A2). In wave 1, 
a total of 18 893 (0.70%) had recorded SARS-CoV-2 
infection, 8560 (0.32%) were admitted to hospital 
with covid-19, 732 (0.03%) were admitted to ICU for 
ventilatory support with covid-19, and 6507 (0.24%) 
died of covid-19 (supplementary table A5). In wave 2, 
a total of 34 519 (1.28%) had recorded SARS-CoV-2 
infection, 4280 (0.16%) were admitted to hospital 
with covid-19, 784 (0.03%) were admitted to ICU for 
ventilatory support with covid-19, and 4108 (0.15%) 
died of covid-19 (supplementary table A5).
adults aged 65 years and under
In wave 1, among adults 65 years and under, in the 
comorbidity adjusted model, living with children 
of any age was not associated with an increased 
risk of recorded SARS-CoV-2 infection or covid-19 
related outcomes, compared with people not living 
with children, except for small increases in the 
risk of infection for adults living with children 
aged 12-18 years and of covid-19 related hospital 
admissions for adults living with children aged 
0-11 and 12-18 years (fig 1). In wave 2, living with 
children was associated with an increased risk of 
recorded SARS-CoV-2 infection and covid-19 related 
hospital admission but was not associated with ICU 
admission. Living with children aged 0-11 years 
was associated with a reduced risk of death from 
covid-19 in both wave 1 and wave 2; we observed no 
increase in risk of death for those living with older 
children.
Our findings with regard to the second wave for 
adults 65 years and under can be contextualised by 
considering the absolute increase in risk of outcomes 
that they represent. Using the overall rate of outcomes 
among people living without children as the baseline, 
we estimate that living with children aged 0-11 years 
was associated with an increase in the number of 
SARS-CoV-2 infections of 40-60 per 10 000 people, 
from 810 to between 850 and 870, and an increase in 
the number of hospital admissions of 1-5 per 10 000 
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people, from 160 to between 161 and 165. Living with 
children aged 12-18 years was associated with an 
increase of 160-190 per 10 000 in the number of SARS-
CoV-2 infections and an increase of 2-6 per 10 000 in 
the number of hospital admissions.
adults aged over 65 years
For adults over 65 years living in a household with 
children, we found no evidence of an association with 
any outcome in wave 1 (supplementary figure A4). In 
wave 2, living with children of any age was associated 
with an increased risk of recorded SARS-CoV-2 
infection but not covid-19 related hospital admission. 
We also found evidence that living with children aged 
0-11 and 12-18 years was associated with an increased 
risk of covid-19 related ICU admission (hazard ratio 
1.86, 95% confidence interval 1.11 to 3.14) and 
covid-19 related death (1.44, 1.05 to 1.97).
control analyses and interactions
In relation to the control outcome of death from non-
covid-19 related causes, in both waves, living with 
children of any age was associated with around a 30% 
reduced risk for adults 65 or under, but risk was not 
reduced for adults over 65 years (fig 1; supplementary 
figure A4). We observed no strong or consistent trends 
in the associations between risks of recorded SARS-
CoV-2 infection or severe outcomes from covid-19 and 
the number of children aged 0-11 years in a household, 
for adults of any age in either wave (supplementary 
table A6).
We explored whether the association between 
household exposure to children and the risk of 
covid-19 outcomes varied by sex or probable shielding 
status in the comorbidity adjusted model (fig 2, fig 
3, fig 4, and fig 5 for adults 65 years and under; 
supplementary figure A5 for adults over 65 years). 
Among adults 65 years and under, we observed no 
consistent patterns of interaction by sex, although in 
both waves the small increase in risk of recorded SARS-
CoV-2 infection among those living with children 
aged 0-11 years was observed in men but not women 
(P for interaction<0.001). For adults over 65 years, 
we observed a greater increase in risk of recorded 
SARS-CoV-2 infection and covid-19 related hospital 
admission for women living with children 0-11 and 
12-18 years than for men.
We found no evidence of important increases in 
risk for any outcome for potentially shielding adults 
65 years and under in wave 1. However, in wave 2, for 
people living with children aged 12-18 years or with 
children aged 0-11 and 12-18 years, the magnitude 
of the increased risk of covid-19 related hospital 
admission was greater in those potentially shielding 
than those not shielding (P for interaction=0.03 
and 0.04, respectively). For death from covid-19, for 
people living with children 12-18 years, we found 
weak evidence of an increased risk in those who were 
shielding (hazard ratio 1.46, 0.95 to 2.24) but not in 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 on 21 M










J: first published as 10.1136/bm






6 doi: 10.1136/bmj.n628 | BMJ 2021;372:n628 | the bmj
Model checking and sensitivity analyses
Among adults 65 years and under, living with only 
children aged 0-11 years was associated with a twofold 
higher risk of being diagnosed with threadworm 
(hazard ratio 2.70, 2.33 to 3.12), with strong evidence 
of an increased risk with increasing number of 
children aged 0-11 in the household. The risk was 
also increased among adults living with only children 
aged 12-18 years, although the increase was of a 
smaller magnitude (hazard ratio 1.30, 1.02 to 1.67) 
(supplementary table A7).
None of the sensitivity analyses materially altered 
the results from the comorbidity adjusted models 
(supplementary figure A6). We detected evidence of 
non-proportional hazards in the comorbidity adjusted 
models for all outcomes (P<0.001). Further assessment 
for non-proportional hazards based on Schoenfeld 
residuals showed evidence of non-proportionality by 
SARS-CoV-2 infection
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 hospital admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 ICU admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 death
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Non-covid-19 death
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
0.98 (0.96 to 1.01)
1.06 (1.05 to 1.08)
1.05 (1.01 to 1.08)
1.22 (1.20 to 1.24)
1.01 (0.97 to 1.05)
1.25 (1.23 to 1.27)
0.92 (0.85 to 1.00)
1.18 (1.06 to 1.31)
1.06 (0.97 to 1.16)
1.26 (1.12 to 1.4)
1.12 (1.01 to 1.23)
1.44 (1.28 to 1.63)
0.91 (0.76 to 1.07)
1.19 (0.98 to 1.43)
1.05 (0.88 to 1.24)
1.13 (0.93 to 1.39)
1.00 (0.81 to 1.23)
1.22 (0.96 to 1.55)
0.71 (0.57 to 0.90)
0.52 (0.35 to 0.78)
0.87 (0.69 to 1.09)
0.97 (0.71 to 1.33)
0.76 (0.56 to 1.03)
0.84 (0.54 to 1.30)
0.62 (0.57 to 0.68)
0.66 (0.57 to 0.75)
0.73 (0.67 to 0.80)
0.76 (0.67 to 0.87)
0.61 (0.54 to 0.69)










































Fig 1 | adjusted hazard ratios for outcomes recorded sars-cov-2 infection, covid-19 related hospital admission, 
covid-19 related intensive care unit (icu) admission, covid-19 related death, and non-covid-19 related death among 
adults aged 65 years and under, for waves 1 and 2 of uK pandemic. comorbidity adjusted model adjusted for age, 
sex, ethnicity, number adults in household, index of multiple deprivation, body mass index, smoking, hypertension 
or high blood pressure, chronic respiratory disease, asthma, cancer, chronic liver disease, stroke or dementia, 
other neurological disease, reduced kidney function, end stage renal disease, solid organ transplant, asplenia, and 
rheumatoid arthritis, systemic lupus erythematosus, psoriasis, or other immunosuppressive condition
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exposure status for reported SARS-CoV-2 infection in 
both waves and for covid-19 related ICU admission 
in wave 1. For all outcomes, we also found evidence 
of non-proportional hazards in several adjustment 
covariates. Therefore, we did a sensitivity analysis 
fitting a time interaction (at 1 April and 1 May 2020 
for wave 1; at 1 November and 1 December in wave 2) 
with these covariates; the results for the main exposure 
from these models were similar to the main analysis 
(supplementary figure A6).
In post hoc analysis, we observed an increased 
risk of recorded SARS-CoV-2 infection and covid-19 
related hospital admission for adults 65 years and 
under living with preschool children aged 0-4 years 
(supplementary figure A7), with magnitudes similar 
to the findings for the 5-11 age group. When we 
accounted for missing ethnicity data through multiple 
imputation, the associations between living with 
children and outcomes remained the same as in the 
primary (complete case) analysis (supplementary 
tables A8 and A9). However, in wave 2, the imputed 
results showed stronger evidence of an increased risk 
of covid-19 related ICU admission for adults living with 
children of all ages.
In quantitative bias analysis, accounting for sha-
red risk of people with young children working in 
occupations with a high risk of SARS-CoV-2 exposure, 
when we assumed an association between being in a 
high risk occupation and developing each outcome of 
1.3 or 2, the hazard ratio for the association between 
having children and the outcomes were lowered 
but the overall conclusions were largely unchanged 
(supplementary table A10 and A11). By contrast, 
when we assumed a hazard ratio between high risk 
occupation and each outcome of 3, the differences 
were more marked (supplementary table A12). In wave 
2, rather than an increased risk of reported SARS-
CoV-2 infection among adults living with only children 
aged 0-11 years, we observed a reduced risk (hazard 
ratio 0.94, 0.93 to 0.95). Risks of reported SARS-CoV-2 
infection among adults living with only children aged 
12-18 years, as well as adults living with children 
SARS-CoV-2 infection
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 hospital admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 ICU admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 death
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
0.92 (0.90 to 0.95)
1.08 (1.04 to 1.12)
1.02 (0.98 to 1.06)
1.09 (1.04 to 1.15)
0.97 (0.93 to 1.01)
1.07 (1.01 to 1.13)
0.85 (0.76 to 0.96)
0.98 (0.88 to 1.08)
0.93(0.81 to 1.05)
1.18 (1.06 to 1.32)
1.08 (0.94 to 1.25)
1.14 (1,00 to 1.29)
0.80 (0.60 to 1.06)
0.96 (0.79 to 1.17)
0.94 (0.70 to 1.26)
1.11 (0.90 to 1.36)
0.71 (0.47 to 1.06)
1.15 (0.90 to 1.46)
0.66 (0.46 to 0.95)
0.75 (0.56 to 0.99)
0.67 (0.45 to 1.00)
0.99 (0.75 to 1.29)
0.45 (0.24 to 0.84)

















































Fig 2 | comorbidity adjusted hazard ratios for each covid-19 outcome, compared with having no children in household, 
by sex, among adults aged 65 years and under for wave 1 of uK pandemic
 on 21 M
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aged 0-11 and 12-18 years, were still increased. For 
covid-19 related hospital admission, the hazard ratio 
reduced toward the null, and we found evidence of an 
increased risk of admission only among adults living 
with children aged 0-11 and 12-18 years.
discussion
During the first wave of the pandemic of SARS-CoV-2 in 
the UK, we found no evidence of substantial increases 
in risk of recorded infection or serious covid-19 
outcomes for adults aged 65 years and under sharing 
a household with children of any age, compared with 
those living without children. However, our results 
show an increased risk of recorded infection and 
covid-19 related hospital admission for adults living 
with children of all age groups in the second wave. In a 
post hoc analysis, separating children aged 0-11 years, 
we found that these increased risks were similar for 
adults living with children of preschool and primary 
school age children. For adults aged over 65 years, we 
also found an increased risk of infection associated with 
living with children of any age and of ICU admission 
and death from covid-19 for those living with children 
aged 0-11 and 12-18 years. In both waves, among 
adults aged 65 years and under, sharing a household 
with children aged 0-11 years was associated with a 
reduced risk of death from covid-19; this was similar in 
magnitude to the reduction in risk of death from causes 
other than covid-19 seen in adults aged 65 years and 
under living with children of all ages.
strengths and limitations of study
Our analysis has several important strengths. Firstly, 
our study is large, providing us with sufficient power 
to examine rarer outcomes. Secondly, we studied 
SARS-CoV-2 infection, with the vast majority of cases 
confirmed by swab testing, and covid-19 related 
clinical outcomes, enabling us to examine associations 
across the range of severity of illness. Thirdly, we 
have done a control analysis of threadworm infection 
in adults, which provides strong evidence that our 
model is able to detect an infection transmitted from 
SARS-COV-2 infection
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 hospital admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 ICU admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 death
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
1.02 (1.01 to 1.04)
1.12 (1.10 to 1.14)
1.23 (1.21 to 1.25)
1.21 (1.18 to 1.23)
1.26 (1.24 to 1.28)
1.24 (1.21 to 1.27)
1.12 (0.97 to 1.29)
1.23 (1.08 to 1.41)
1.13 (0.96 to 1.33)
1.36 (1.18 to 1.57)
1.41 (1.18 to 1.68)
1.47 (1.26 to 1.72)
1.02 (0.74 to 1.41)
1.27 (1.02 to 1.58)
1.11 (0.79 to 1.58)
1.14 (0.90 to 1.45)
1.21 (0.81 to 1.83)
1.22 (0.92 to 1.62)
0.31 (0.13 to 0.70)
0.65 (0.41 to 1.02)
0.86 (0.50 to 1.49)
1.03 (0.71 to 1.49)
1.22 (0.65 to 2.30)

















































Fig 3 | comorbidity adjusted hazard ratios for each covid-19 outcome, compared with having no children in household, 
by sex, among adults aged 65 years and under for wave 2 of uK pandemic
 on 21 M
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children to adults, with, as we would anticipate, risk 
increasing with the number of children in a household 
and with the strongest association seen in younger 
children. Finally, we have used the depth of linked UK 
healthcare and electronic health records datasets to 
enable detailed adjustment for a range of covariates 
and provide rapid evidence related to wave 2 of the 
covid-19 pandemic.
The study also has some limitations. Owing to 
geographical variation in the choice of electronic 
health record system, our large population may not 
be fully representative of the UK. We stratified by 
region through the Sustainability and Transformation 
Partnership, but we could not account for local 
variation in the prevalence of SARS-CoV-2. We did not 
examine the direct association between children and 
adults within a household testing positive for SARS-
CoV-2, as a substantial proportion of infections in this 
age group will be asymptomatic or undiagnosed.29 
In relation to the data used to define the outcomes, 
changing availability of SARS-CoV-2 testing over 
the period of the study means that results related 
to testing during wave 1 could have been biased by 
characteristics of people in high risk jobs. Additionally, 
results for the infection outcome could have been 
biased if people living with children were more likely 
to seek testing, although we saw similar proportions of 
infections defined by swab testing in those living with 
and without children, and we would not anticipate 
that this would create bias for the other outcomes. Data 
on hospital admissions are not available until after a 
patient has been discharged and thus may be biased 
towards capturing shorter admissions for the later part 
of wave 2, although early censoring of Secondary Uses 
Service data in a sensitivity analysis did not change our 
findings. The threshold for hospital treatment may have 
changed between wave 1 and wave 2, with increased 
awareness of the risks of hypoxia and availability 
of treatments such as dexamethasone. However, we 
would not anticipate this having a substantial effect 
on admissions for people aged 65 years and under, 
and we would have anticipated lower admission rates 
SARS-CoV-2 infection
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 hospital admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 ICU admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 death
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
0.99 (0.96 to 1.02)
0.94 (0.90 to 0.99)
1.05 (1.01 to 1.09)
1.04 (0.98 to 1.10)
1.02 (0.98 to 1.06)
0.99 (0.92 to 1.06)
0.90 (0.82 to 0.99)
0.97 (0.84 to 1.11)
1.06 (0.95 to 1.17)
1.08 (0.93 to 1.25)
1.15 (1.03 to 1.28)
1.03 (0.85 to 1.24)
0.83 (0.68 to 1.01)
1.11 (0.83 to 1.46)
0.99 (0.81 to 1.22)
1.18 (0.88 to 1.58)
1.02 (0.81 to 1.29)
0.91 (0.60 to 1.38)
0.61 (0.46 to 0.81)
0.93 (0.66 to 1.30)
0.83 (0.63 to 1.10)
0.93 (0.64 to 1.34)
0.72 (0.50 to 1.04)

















































Fig 4 | comorbidity adjusted hazard ratios for each covid-19 outcome, compared with having no children in household, 
by shielding status, among adults aged 65 years and under for wave 1 of uK pandemic
 on 21 M
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among adults living with children owing to lower levels 
of comorbidities. ICNARC data do not capture patients 
admitted to all ICUs, particularly for the newer “surge” 
capacity.
Occupation was an unmeasured confounder both in 
terms of exposure to SARS-CoV-2 (such as healthcare 
workers and other high risk workers) and degree 
of contact with children outside the home (such as 
nursery workers). We sought to explore the potential 
effect of lack of occupational information on our 
results through a quantitative bias analysis. This 
suggested that our findings were not materially altered 
unless a substantial proportion of the population 
were both more likely to live with children and to 
work in roles strongly associated with an increased 
risk of SARS-CoV-2 infection. However, our highest 
assumed estimate for risk of infection, taken from 
a study of healthcare workers,22 is likely to be a 
substantial overestimate for the average increased 
risk for all key workers. We were not able to adjust 
for confounding by previous comorbidities that 
affected both ability or choice to have children and 
subsequent risk of development of severe outcomes 
from covid-19. However, results of models with and 
without adjustment for baseline comorbidities show 
no important differences.
We have probably misclassified the degree of 
contact with children in some situations, such as for 
divorced parents, and limitations in the data may 
mean misclassification of the number of people living 
in a household—for example, when people have not 
updated their address with their general practice 
following a house move. In our main analysis, we 
have not adjusted for the number of children living 
in a household; therefore, our analysis represents the 
overall association of living with children in that age 
group, and we acknowledge that risk may vary by the 
number of children. However, we did not detect strong 
evidence of higher risk for adults living with increasing 
numbers of younger children. Finally, we assume 
a constant relation for infections between people 
through clustering at the household level, rather than 
SARS-COV-2 infection
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 hospital admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 ICU admission
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
Covid-19 death
  Only children aged 0-11 years
  Only children aged ≥12 years
  Children aged 0-11 and ≥12 years
1.06 (1.05 to 1.08)
1.06 (1.04 to 1.09)
1.22 (1.20 to 1.24)
1.21 (1.17 to 1.24)
1.24 (1.22 to 1.27)
1.28 (1.24 to 1.32)
1.17 (1.04 to 1.31)
1.20 (1.01 to 1.42)
1.15 (1.01 to 1.32)
1.47 (1.23 to 1.74)
1.34 (1.15 to 1.54)
1.71 (1.40 to 2.09)
1.15 (0.92 to 1.43)
1.26 (0.92 to 1.72)
1.09 (0.86 to 1.39)
1.22 (0.87 to 1.71)
1.07 (0.80 to 1.43)
1.58 (1.08 to 2.33)
0.48 (0.29 to 0.80)
0.59 (0.32 to 1.09)
0.69 (0.44 to 1.07)
1.46 (0.95 to 2.24)
0.63 (0.35 to 1.12)

















































Fig 5 | comorbidity adjusted hazard ratios for each covid-19 outcome, compared with having no children in household, 
by shielding status, among adults aged 65 years and under for wave 2 of uK pandemic
 on 21 M
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detailed modelling of how infections are transmitted 
within households.
comparison with other studies
One recent cohort study has adopted a similar approach 
to ours to explore potential cross immunity from other 
coronavirus infections among people living with 
young children. This study linked information on more 
than 300 000 healthcare workers and other adults in 
their household in Scotland to determine whether the 
risk of SARS-CoV-2 infection and severe outcomes from 
covid-19 differed between adults living in households 
with and without children aged 0-11 years.30 During 
the period from March to October 2020, they found a 
reduced risk of testing positive for SARS-CoV-2 for those 
living with young children but no difference in risk of 
covid-19 requiring hospital admission. Differences in 
power, greater and more consistent risk of occupational 
exposure among healthcare workers in their cohort, 
and different epidemic trajectories between Scotland 
and England make direct comparisons between our 
results difficult. However, our results show no evidence 
that cross reactive immunity protects against SARS-
CoV-2 infection and covid-19 outcomes in the general 
population.
Policy implications
Given this, what are the factors likely to underlie our 
findings, and in particular the difference in results 
between waves 1 and 2? An important difference is 
that for most of the time period of wave 1, schools were 
closed except to children of key workers and vulnerable 
children. However, they reopened after the holidays 
at the beginning of September and remained open 
throughout the period of wave 2 in this study. Data from 
population based studies show that the reopening of 
schools was temporally associated with progressively 
increasing prevalence of SARS-CoV-2 among children 
of all ages.31 32 The role of schools in transmission 
of SARS-CoV-2 and the effect of school closures on 
its prevalence remain uncertain. Our finding of an 
increased risk to adults who live with children beyond 
SARS-CoV-2 transmission within schools during wave 
2 may have been partly driven by indirect effects—for 
example, school opening may have allowed parents to 
travel to work outside the home, increasing potential 
contacts. Potential differences also exist in the 
behaviours of households with children that also lead 
to increased social contacts, such as the need for child 
care, greater likelihood of play and activity outside of 
schools, and more frequent shopping. Furthermore, 
policy decisions around schools must take into 
account the potential harms associated with school 
closures, such as adverse mental health consequences 
and worsening inequalities.33-35
Although even covid-19 infection that does not 
lead to hospital admission may be associated with 
serious sequelae, that we have not found a materially 
increased risk of ICU admission or death overall among 
adults aged 65 years and under living with children 
is reassuring. However, signals of harm are apparent 
in some subgroups, and confidence intervals are 
compatible with an increase in risk, particularly given 
limited numbers of ICU admissions. Our findings of 
no increase in risk of severe outcomes from covid-19 
despite an increased risk of infection and hospital 
admission could be explained by confounding if adults 
living with children had a greater risk of infection in 
wave 2 but are healthier than people without children. 
This explanation is supported by our finding of a 
substantially lower risk of mortality from causes other 
than covid-19 among adults aged 65 years and under 
living with children of any age. Parents are known to 
have lower all cause mortality than people without 
children.36 37 The protective mechanisms of having 
children are likely to be multifactorial and may include 
healthier behaviours among parents—for example, in 
relation to smoking and alcohol,38 39 self-selection of 
healthier people becoming parents,40 and beneficial 
changes in immune function from exposure to young 
children.41 In this context, we did not observe a lower 
risk of death from covid-19 for adults aged 65 years and 
under, compared with adults living without children, 
except for those living with children aged 0-11 years.
conclusions
During the first wave of the UK pandemic, for adults 
65 years and under living with children, we found no 
evidence of a markedly increased risk of SARS-CoV-2 
infection or severe covid-19 outcomes. However, we 
found evidence of increased risk of infection and 
hospital admission with covid-19 for adults living 
with children during wave 2, although the absolute 
increases in risk were low. These increased risks 
during wave 2 were observed at a time when schools 
remained open, raising the possibility that widespread 
school attendance may have led to increased risks to 
households, but other differences between households 
with and without children could also have explained 
these observational findings. Close monitoring and 
evaluation as schools re-open will be crucial to inform 
ongoing policy.
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